CONTROLLED SUBSTANCE: PATIENT REPORT                            S.B. 166 (S-1) & 167 (S-2):

                                                                                                    SUMMARY OF BILL

                                                                                                  ON THIRD READING

Senate Bill 166 (Substitute S-1 as reported)

Senate Bill 167 (Substitute S-2 as reported by the Committee of the Whole)

Sponsor:  Senator Tonya Schuitmaker

Committee:  Health Policy

CONTENT

The bills would amend the Public Health Code to do the following:

-- Require licensed prescribers, beginning January 1, 2020, to obtain and review a report concerning a patient from the Department of Licensing and Regulatory Affairs' electronic system for monitoring Schedule 2, 3, 4, and 5 controlled substances, before prescribing or dispensing a controlled substance to that patient.

-- Provide that the requirement would not apply if the dispensing occurred in a licensed hospital and the controlled substance were for the patient's inpatient use.

-- Include a violation of the proposed requirement among the grounds for disciplinary action.

-- Prescribe disciplinary sanctions, including license revocation, for a violation.

The bills are tie-barred.

MCL 333.7303a (S.B. 166)                                        Legislative Analyst:  Stephen Jackson

       333.16221 & 333.16226 (S.B. 167)

FISCAL IMPACT

The bills would have no fiscal impact on State or local government.

Date Completed:  6-21-17                                                     Fiscal Analyst:  Josh Sefton

This analysis was prepared by nonpartisan Senate staff for use by the Senate in its deliberations and does not constitute an official statement of legislative intent.